• SELECT SITE CURRENCY
Select a currency for use throughout the site
Company Analysis - Novartis AG
RNCOS E-Services Private Limited, August 2011, Pages: 35
Company Analysis assists individual investors, managers and companies in evaluating opportunities, trends, market innovations as well as in selecting appropriate information solutions in order to make effective investment decisions.
The study covers information on the business structure, areas of operation, products and services offered by the company. It comprises SWOT analysis, Key Ratios, and financials that aid investors in gaining an insight into the company's performance.
The report is an outcome of extensive research and makes use of data provided by various credible publications, trade journals, industry associations, and the company sources.
- Provides a comprehensive version of the company's performance
- Offers key financial data, ratio and SWOT analysis
- Tracks major M&A trends and developments
- Business Profile, SWOT analysis and financial information on top competitors
- View on the company by our analysts
- Supplemented with graphs and tabular information wherever necessary
1. Company Overview
1.2 Business Overview
1.3 Organizational Structure
1.4 Major Mergers & Acquisitions
1.5 Ticker Codes at various Stock Exchange Listings
1.6 Management Profile
2. Product & Services
2.1 Product & Services - An Overview
2.2 Revenue Summary by Business Division
2.3 Revenue Summary by Geographical Distribution
3. Financial Information for the Fiscal Year
3.1 Financial Summary for the Fiscal Year
3.2 Breakup of Revenue & Sales Trends
3.3 Ratio & Market Indicators
3.4 Earning & Income Estimates
3.5 Stock Analysis
4. SWOT Analysis
5. Top Competitors (Key Financials & SWOT Analysis)
5.1 Amgen, Inc.
5.3 GlaxoSmithKline plc
5.4 Pfizer Inc.
6. Analyst View
Table 1-1: Novartis AG - Major Mergers & Acquisitions (2008-2011)
Table 1-2: Novartis AG - Ticker Codes at various Stock Exchange
Table 1-3: Novartis AG - Key Management People
Table 3-1: Novartis AG - Financial Overview (Million US$), 2010
Table 3-2: Novartis AG - Breakup of Revenue & Sales (Million US$), 2008-2010
Table 3-3: Novartis AG - Key Financial Ratios (2008-2010)
Table 3-4: Novartis AG - Earning & Income Estimates (Million US$), 2008-2010
Table 5-1: Amgen, Inc. - Key Financials (Million US$), 2008-2010
Table 5-2: Amgen, Inc. - SWOT Analysis
Table 5-3: Sanofi-Aventis - Key Financials (Million US$), 2008-2010
Table 5-4: Sanofi-Aventis - SWOT Analysis
Table 5-5: GlaxoSmithKline plc - Key Financials (Million US$), 2008-2010
Table 5-6: GlaxoSmithKline plc - SWOT Analysis
Table 5-7: Pfizer Inc. - Key Financials (Million US$), 2008-2010
Table 5-8: Pfizer Inc. - SWOT Analysis
Figure 2-1: Novartis AG - Revenue by Business Division (Million US$), 2009 & 2010
Figure 2-2: Novartis AG - Revenue by Geographical Distribution (Million US$), 2009 & 2010
Figure 3-1: Novartis AG - Stock Chart
- Amgen, Inc.
- GlaxoSmithKline plc
- Pfizer Inc.